Interview with Kate Lynch, CEO, Generic Medicines Industry Association (GMiA)
In trying to be an effective association and positively influence the environment for your members, what have been…
Address: PO Box 222, Pymble BC NSW 2073,Australia
Tel:
The Generic Medicines Industry Association (GMiA) is a representative body of generic medicine suppliers in Australia. Its members ensure that all Australians are offered the highest quality generic medicines in the world whilst providing affordable community health outcomes that benefit all Australians.
The guiding principles of the members of GMiA are:
To support the long term sustainability of the PBS by ensuring the timely and cost effective provision of Generic Medicines to consumers.
To support the quality use of medicines (QUM) in partnership with other stakeholders.
To support the development of policies that facilitate timely access to Generic Medicines for all Australians.
To support the development of policies that promote the continued viability of a local manufacturing base for Generic Medicines (for domestic and export markets).
To encourage a high level of awareness and general knowledge of the safety, efficacy and appropriate interchangeability of Generic Medicines amongst Healthcare Professionals, Government and Consumers.
To support balanced intellectual property rights in the pharmaceutical sector that enable timely, cost effective access to Generic Medicines.
To enhance the accountability of Members by establishing a complaints handling mechanism that is both readily accessible and transparent.
To reduce actual and potential conflicts of interest between Members and Healthcare Professionals responsible for prescribing and dispensing prescription medicines by establishing an Educational Event reporting procedure with independent review.
In trying to be an effective association and positively influence the environment for your members, what have been…
To begin, would you please introduce GMIA to Pharmaceutical Executive readers? The GMIA is an industry…
Janssen Australia & New Zealand’s Bruce Goodwin argues that greater adoption of patient-centric practices…
Can you start by giving our readers a brief overview of the company’s history here and your most notable…
Would you begin by outlining the role & importance of George Clinical within the George Institute, highlighting…
Would you begin by giving an introduction to our international readers of the institute, highlighting recent…
For those that are not familiar with your name, would you start by introducing yourself? After obtaining my PhD in…
Rare Voices Australia is a new organisation that has been established after the national rare diseases symposium in…
In some ways the Australian medicines industry is going through the same restructuring and challenges as the…
Can you outline the significance of the current PBS to the industry and in particular the impact it has on service…
Speaking to the Australian environment, how would you rate the market in terms of companies like Swisse? After…
In our interviews we have been hearing two opinions on the success of PBS reforms: that it works as it should in…
Dr Bernadette Morris-Smith has also participated in this interview TranScrip Partners is by now a well-established…
Dr. Reddy’s entered Australia under your leadership. Would you outline the key milestones & achievements?…